FRED Retrospective Study of Intracranial Aneurysms Treatment

Launched by MICROVENTION-TERUMO, INC. · May 20, 2025

Keywords

ClinConnect Summary

The FRED Retrospective Study is looking at how safe and effective a treatment called the Flow Re-Direction Endoluminal Device System (FRED) is for people with intracranial aneurysms, which are bulges in the blood vessels in the brain. This study will focus on patients in mainland China who have already been treated with FRED, analyzing their medical records to gather information about their outcomes over time.

To be eligible for this study, participants must be individuals who have received treatment with the FRED device. There are no specific exclusions, meaning that anyone who meets the criteria will be included. While the study is not yet recruiting participants, those who do take part can expect their past treatment information to be reviewed to help doctors understand the long-term effects of this device. This research is important as it will provide valuable insights into how well FRED works and its safety for treating aneurysms.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • People in China mainland who have been treated with FRED. The patients for whom clinical data are available
• Exclusion Criteria:
• • Patients who met the inclusion criteria at all time points were required to be included in the study. Therefore, no specific exclusion criteria were set.